Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05253131
Title Trial of Selumetinib and AZD5153 With Durvalumab for Sarcomas
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications

desmoplastic small round cell tumor

malignant fibrous histiocytoma

osteosarcoma

neurofibroma

malignant peripheral nerve sheath tumor

Ewing sarcoma

sarcoma

synovial sarcoma

bone sarcoma

rhabdomyosarcoma

Therapies

AZD5153 + Durvalumab + Selumetinib

AZD5153 + Selumetinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.